The adaptations of a quality of life questionnaire for routine use in clinical practice: the Chronic Respiratory Disease Questionnaire in cystic fibrosis

被引:14
作者
Bradley, J
Dempster, M [1 ]
Wallace, E
Elborn, S
机构
[1] Queens Univ Belfast, Hlth & Social Care Res Unit, Belfast BT12 6BJ, Antrim, North Ireland
[2] Univ Ulster, Jordanstown, North Ireland
[3] Belfast City Hosp, Belfast BT9 7AD, Antrim, North Ireland
关键词
internal consistency; construct validity; quality of life; Chronic Respiratory Disease Questionnaire (CRDQ); cystic fibrosis;
D O I
10.1023/A:1026437214170
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
The assessment of quality of life (QoL) is to assessment of spirometric measures of lung function. Those patients whose lung function was stable at the time of study and who could attend for a retest within 14 days were asked to complete the questionnaire at a subsequent visit (n=10). The mean interval between visits was 7 days (range 5-14 days). Correlations between spirometry and CRDQ dimensions ranged from -0.003 to 0.426. The fatigue, emotion and mastery dimensions showed high internal consistency and adequate construct validity. In the small number of patients suitable for retest, the results indicated that the dimensions exhibited adequate test-retest reliability. In contrast, low internal consistency was demonstrated for the dyspnoea dimension. The fatigue, emotion and mastery dimensions could be reduced, in terms of their number of items, without a substantial loss in explanatory power. This study suggests that QoL measurement can be made convenient and, thus, more easily accessible for routine clinical assessment. Qual. Life Res. 8:65-71 (C) 1999 Kluwer Academic Publishers.
引用
收藏
页码:65 / 71
页数:7
相关论文
共 19 条
[1]  
Bland M, 1996, INTRO MED STAT
[2]   MEASURING THE QUALITY-OF-LIFE BEFORE AND AFTER BILATERAL LUNG TRANSPLANTATION IN PATIENTS WITH CYSTIC-FIBROSIS [J].
BUSSCHBACH, JJV ;
HORIKX, PE ;
VANDENBOSCH, JMM ;
DELARIVIERE, AB ;
DECHARRO, FT .
CHEST, 1994, 105 (03) :911-917
[3]  
CONGLETON J, 1996, ISRAEL J MED SCI, V32, P5181
[4]  
deJong W, 1997, PEDIATR PULM, V23, P95, DOI 10.1002/(SICI)1099-0496(199702)23:2<95::AID-PPUL4>3.0.CO
[5]  
2-N
[6]  
DODD ME, 1996, ISRAEL J MED SCI, V32, pS181
[7]   CYSTIC-FIBROSIS - CURRENT SURVIVAL AND POPULATION ESTIMATES TO THE YEAR 2000 [J].
ELBORN, JS ;
SHALE, DJ ;
BRITTON, JR .
THORAX, 1991, 46 (12) :881-885
[8]   HEART-LUNG TRANSPLANTATION IN CYSTIC-FIBROSIS - PREDICTIONS FOR THE NEXT DECADE IN ENGLAND AND WALES [J].
ELBORN, JS ;
SHALE, DJ ;
BRITTON, JR .
RESPIRATORY MEDICINE, 1994, 88 (02) :135-138
[9]  
GLYZEWSKI D, 1994, MED CARE, V32, P965
[10]   A MEASURE OF QUALITY-OF-LIFE FOR CLINICAL-TRIALS IN CHRONIC LUNG-DISEASE [J].
GUYATT, GH ;
BERMAN, LB ;
TOWNSEND, M ;
PUGSLEY, SO ;
CHAMBERS, LW .
THORAX, 1987, 42 (10) :773-778